Results 161 to 170 of about 72,133 (313)

Application of the Da Vinci Single‐Port (SP) Robot in General Surgery: A First Systematic Review

The International Journal of Medical Robotics and Computer Assisted Surgery, Volume 21, Issue 6, December 2025.
ABSTRACT Introduction Minimally invasive surgery has revolutionized surgical practice by reducing surgical trauma and enhancing recovery. In this context, the da Vinci SP System represents a major technological advancement. This review aims to report its clinical applications in general surgery, evaluating associated outcomes and potential advantages ...
Antonio Cubisino, Maurice Chazal, Fabrizio Panaro   +2 more
wiley   +1 more source

A Qualitative Assessment of Patient Satisfaction with Radical Cystectomy for Bladder Cancer at a Single Institution: How Can We Improve?

Research and Reports in Urology, 2020
Lukas Hockman,1 Jacob Bailey,1 Jacob Sanders,1 Catherine Muzzey,1 Mark Wakefield,1 Amy Christensen,2 Katie Murray1 1Division of Urology, Department of Surgery, School of Medicine, University of Missouri, Columbia, Missouri, USA; 2Department of Health ...
Hockman L, Bailey J, Sanders J, Muzzey C, Wakefield M, Christensen A, Murray K   +6 more
doaj  

Functional and Oncological Outcomes of Genital Sparing Cystectomy in Zagazig University Hospitals [PDF]

openalex   +1 more source

BCG Intolerance in Nonmuscle Invasive Bladder Cancer—A Systematic Review

ANZ Journal of Surgery, Volume 95, Issue 12, Page 2460-2467, December 2025.
ABSTRACT Background Most patients with localized bladder cancer are initially managed with endoscopic resection. For high‐grade nonmuscle invasive bladder cancer (NMIBC), intravesical Bacillus Calmette‐Guerin (BCG) therapy is the gold standard adjuvant treatment.
Claris Oh, Georgia Bourlotos, Michael O'Callaghan, Luke Grundy, Matthew Hong   +4 more
wiley   +1 more source

Radiomics-guided therapy for bladder cancer: Using an optimal biomarker approach to determine extent of bladder cancer invasion from t2-weighted magnetic resonance images [PDF]

, 2018
Baumann, Brian C, Chen, Jerry, Christodouleas, John P, Guzzo, Thomas J, Mamtani, Ronac, Tong, Yubing, Torigian, Drew A, Udupa, Jayaram K, Venigalla, Sriram, Wang, Chuang   +9 more
core   +2 more sources

Sentinel lymph node staging in urological cancer surgery: advances in imaging, intra‐operative detection and translational research

BJU International, Volume 136, Issue 6, Page 979-989, December 2025.
Objectives To review the clinical utility, outcome and possible future applications of sentinel lymph node biopsy (SLNB) in penile cancer (PeC), bladder cancer (BCa), prostate cancer (PCa), testicular cancer (TCa) and renal cell carcinoma (RCC), focusing in particular on current SLNB standards and exploring advancements in imaging agents, intra ...
Erik J. van Gennep, Gijs H. KleinJan, Teele Kuusk, Rick W.A. Verdijk, Esther M.K. Wit, Bas W.G. van Rhijn, Axel Bex, Laura S. Mertens   +7 more
wiley   +1 more source

Carbon footprint and staff demands of surgery and chemoradiation for muscle‐invasive bladder cancer

BJU International, Volume 136, Issue 6, Page 1048-1056, December 2025.
Objective To calculate the environmental and labour impact of two complete care pathways for patients with muscle‐invasive bladder cancer (MIBC) with similar oncological outcomes: radical cystectomy (RC) and chemoradiation (CRT), by quantifying the total carbon footprint and staff demands.
Vera C. Rutten, Simone A. W. Hesseling, Martine Franckena, Tahlita C. M. Zuiverloon, Debbie G. J. Robbrecht, Maarten J. IJzerman, Wenxin Lin, Daan Mes, Nicole Hunfeld, Joost L. Boormans   +9 more
wiley   +1 more source

Incidence and risk factors for postoperative vaginal events following radical cystectomy for bladder cancer: a nationwide population‐based study

BJU International, Volume 136, Issue 6, Page 1128-1136, December 2025.
Objective To estimate the probability of vaginal events (diagnosis and/or surgery) following radical cystectomy (RC) and explore possible risk factors in a nationwide population‐based observational registry based study. Patients and Methods Women undergoing RC for urinary bladder cancer in Sweden, from 1 January 1997 to 31 December 2019, were ...
Elin Kalén, Charlotte Ginstman, Fredrik Liedberg, Oskar Hagberg, Martin Holmbom, Tomas Jerlström, Staffan Jahnson, Truls Gårdmark, Viveka Ströck, Lars Holmberg, Christel Häggström, Firas Aljabery   +11 more
wiley   +1 more source

Zebrafish Xenograft Model for Predicting Cisplatin Efficacy in Muscle‐Invasive Bladder Cancer

Cancer Science, Volume 116, Issue 12, Page 3376-3387, December 2025.
This study establishes a zebrafish patient‐derived xenograft (zPDX) model optimized for predicting cisplatin sensitivity in muscle‐invasive bladder cancer. Through technical validation and correlation with clinical outcomes, the model demonstrated its potential as a rapid, cost‐effective platform for individualized chemotherapy response assessment ...
Yusuke Sugino, Xin Bao, Sho Sekito, Shiori Miyachi, Takumi Kageyama, Takeshi Sasaki, Kouhei Nishikawa, Toshio Tanaka, Manabu Kato, Yasuhito Shimada, Keishi Takano, Raku Son, Liqing Zang, Kenji Nakayama, Masatoshi Watanabe, Yasuhiro Murakawa, Takahiro Inoue   +16 more
wiley   +1 more source

Current Status and Future Perspectives of Molecular Residual Disease Testing in Genitourinary Cancers

International Journal of Urology, Volume 32, Issue 12, Page 1735-1745, December 2025.
ABSTRACT While the clinical outcome for patients with resectable solid tumors has improved in recent years, the risk of postoperative recurrence underscores the need for effective monitoring in cancer patients. Molecular residual disease (MRD) refers to the presence of microscopic cancer that remains undetectable on conventional imaging or pathology ...
Taigo Kato, Shugo Yajima, Yoshiaki Nakamura, Shin Kobayashi, Hideaki Miyake   +4 more
wiley   +1 more source